ng-nitroarginine methyl ester has been researched along with Cardiac Complex, Premature in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azev, OA; Koulchitsky, SV; Kulchitsky, VA; Subbotin, OV | 1 |
| Papp, JG; Parratt, JR; Szekeres, L; Vegh, A | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Cardiac Complex, Premature
| Article | Year |
|---|---|
NO-ergic mechanisms are implicated in a disturbed cardiac rhythm after systemic application of lipopolysaccharide E. coli to rats.
Topics: Animals; Bradycardia; Cardiac Complexes, Premature; Enzyme Inhibitors; Escherichia coli; Guanidines; Heart Rate; Injections, Intravenous; Jugular Veins; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2002 |
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arginine; Blood Pressure; Bradykinin; Cardiac Complexes, Premature; Coronary Vessels; Dogs; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Tachycardia, Supraventricular; Ventricular Fibrillation | 1993 |